Scientists are racing to discover new antibiotics that can defeat these drug-resistant superbugs. So how is the newly developed antibiotic clovibactin different?
Academic rigor, journalistic flair
The Peter Doherty Institute for Infection and Immunity
The Doherty Institute is a world-class institute combining research, teaching, public health and reference laboratory services, diagnostic services and clinical care into infectious diseases and immunity. The establishment of the Doherty Institute represents a radical change in the capacity of Australia and the world to detect, investigate and respond to existing, emerging and re-emerging infectious diseases and agents, with a major focus on diseases that pose serious public and global health threats such as influenza, tuberculosis, HIV, viral hepatitis and drug resistant bacteria. The Doherty’s activities are multi-disciplinary and cross-sectoral, placing great emphasis on translational research and improving clinical outcomes. Teams of interdisciplinary scientists, clinicians and epidemiologists collaborate on a wide spectrum of activities - from basic immunology and discovery research, to the development of new vaccines and new preventative and treatment methods, to surveillance and investigation of disease outbreaks.
Links
Displaying 1 - 20 of 72 articles
Firstly, there is no such thing as ‘too much’ immunity. Beyond the regular side-effects of a vaccine, there are no known additional risks to being re-vaccinated soon after an infection.
People in disadvantaged communities are less likely to access COVID antivirals. That needs to change.
La grippe aviaire connaît une épidémie d’un niveau inédit, et des victimes humaines ont été confirmées. Quand une maladie animale peut-elle frapper notre espèce ? Quels sont les risques ?
Measles is an extremely contagious disease but, thanks to immunisation, is now rare in Australia.
Virus yang menyebabkan flu burung adalah spesies yang sama yang menyebabkan influenza pada manusia musiman, flu babi, flu kuda, dan flu anjing, walaupun subtipe dan strain yang berbeda terlibat.
While a small proportion of people have become ill while in contact with infected birds, there is no evidence it has spread from human to human.
Analysis of Victoria’s winter COVID wave found Paxlovid and Lagevrio reduced the risk of hospitalisation and death. The results were better for Paxlovid, but not everyone can take it.
There are so many forms of the virus, it’s hard to keep up. Here’s what to expect next as the virus mutates and recombines.
Authorities have been warned about five virus families that could cause future pandemics. Here are snapshots of the diseases each can cause and why we should be worried.
Karena Omicron telah menyebar dengan cepat, dan memiliki banyak kesempatan untuk bermutasi, Omicron juga memperoleh mutasi spesifiknya sendiri.
It’s hard to keep up. But new Omicron sub-variants are emerging that may lead to reinfections and another spike in cases.
With low COVID vaccination coverage in southern Africa, some have suggested global vaccine inequities may be responsible for the emergence of Omicron.
Protection from infection wanes over time. So boosters will offer extra protection and hopefully reduce the spread of the virus even further.
As Australia moves to the next phase of managing COVID-19, these tests will become more commonplace.
We found two small air cleaners in a single hospital room could clear 99% of potentially infectious COVID aerosols within 5.5 minutes.
The evidence suggests antigen tests are most accurate when the viral load is highest and when a person is likely to be most infectious.
Bahkan jika kita menemukan definisi tentang vaksin “terbaik”, kita tidak memiliki pilihan yang mewah, ketika persediaan vaksin terbatas.
Even if we came up with a definition of what makes the “best” vaccine, we don’t have the luxury of choice, when vaccines are in short supply.
The infection of a Victorian aged-worker who had received their first COVID vaccine dose isn’t completely surprising. We need two doses for optimal protection.
Authors
-
Research officer, The Peter Doherty Institute for Infection and Immunity
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Professor of virology and theme leader for viral infectious diseases, The Peter Doherty Institute for Infection and Immunity
-
Professor of Microbiology, The Peter Doherty Institute for Infection and Immunity
-
Postdoctoral researcher, The Peter Doherty Institute for Infection and Immunity
-
Laboratory Head, The Peter Doherty Institute for Infection and Immunity
-
Professor, The Peter Doherty Institute for Infection and Immunity
-
Senior research fellow, The Peter Doherty Institute for Infection and Immunity
-
Professor, The Peter Doherty Institute for Infection and Immunity
-
Research Fellow, The Peter Doherty Institute for Infection and Immunity
-
Post doctoral researcher and medical epidemiologist, The Peter Doherty Institute for Infection and Immunity
-
Honorary Clinical Fellow, Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity
-
Molecular microbiologist; laboratory head, The Peter Doherty Institute for Infection and Immunity
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Postdoctoral researcher, The Peter Doherty Institute for Infection and Immunity
